Keyphrases
Concanavalin A (Con A)
100%
Acute Hepatitis
100%
3-aminobenzamide
100%
Antioxidative Mechanism
100%
PARP Inhibitor (PARPi)
44%
Macrophages
33%
Scavenger
22%
Tissue Damage
22%
N-acetylcysteine
22%
Diphenyleneiodonium
22%
Inflammation
11%
Inflammatory Cytokines
11%
Therapeutic Effect
11%
Transcriptional Activity
11%
T Cells
11%
Lipopolysaccharide
11%
Hydrogen Peroxide
11%
Liver Tissue
11%
In Vitro Assay
11%
Liver Damage
11%
In Vivo Effects
11%
Ability to Act
11%
Inducible Nitric Oxide Synthase
11%
Liver Injury
11%
Liver Hepatitis
11%
Inflammation Oxidative Stress
11%
RAW264.7 Macrophages
11%
ROS Scavenger
11%
ROS Formation
11%
LPS-stimulated Macrophages
11%
NO Production
11%
ConA-induced Liver Injury
11%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Antioxidant
100%
Concanavalin A
100%
3 Aminobenzamide
100%
Acute Hepatitis
100%
Tumor Necrosis Factor
55%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
44%
Liver Injury
33%
Inflammation
22%
Mouse
22%
Lipopolysaccharide
22%
Tissue Injury
22%
Acetylcysteine
22%
Diphenyliodonium Salt
22%
Cytokine
11%
Therapeutic Effect
11%
Hydrogen Peroxide
11%